您当前的位置:
首页 >
文章列表页 >
Study of health state disutility value estimation of malignant tumor drugs-related adverse events :a systematic review
更新时间:2022-11-09
    • Study of health state disutility value estimation of malignant tumor drugs-related adverse events :a systematic review

    • China Pharmacy   Vol. 33, Issue 14, (2022)
    • Published:2022

    扫 描 看 全 文

  • LU Yuqiong, DAI Zhanjing, LU Yun, et al. Study of health state disutility value estimation of malignant tumor drugs-related adverse events :a systematic review. [J]. China Pharmacy 33(14).(2022) DOI:

  •  
  •  

0

Views

6

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

消渴丸对比格列本脲治疗2型糖尿病疗效与安全性的系统评价
埃克替尼治疗晚期非小细胞肺癌的系统评价
保肝药物治疗药物性肝损伤系统评价的再评价
茵栀黄口服液辅助治疗新生儿黄疸有效性和安全性的系统评价
康莱特注射液联合放疗用于非小细胞肺癌的系统评价

Related Author

WANG Yong-zhong
LI Ying
LI Xiang
LUO Huan
JIANG Hui
LI Ying
KUANG Chen
CHEN Min

Related Institution

No data
0